Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
Chemico-biological interactions • Vol. 205, Issue 1 • 2013
The use of sibutramine in the management of obesity and related disorders: an update.
Vascular health and risk management • Vol. 5, Issue 1 • 2009
Sibutramine: current status as an anti-obesity drug and its future perspectives.
Expert opinion on pharmacotherapy • Vol. 9, Issue 12 • 2008
Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
The Journal of pharmacology and experimental therapeutics • Vol. 321, Issue 2 • 2007